FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.

about

FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.

Item

http://www.wikidata.org/entity/Q38897134

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

FGFR2 mutations are associated ...... ecologic Oncology Group study.

@en

type

Item

label

FGFR2 mutations are associated ...... ecologic Oncology Group study.

@en

prefLabel

FGFR2 mutations are associated ...... ecologic Oncology Group study.

@en

P1476

FGFR2 mutations are associated ...... ecologic Oncology Group study.

@en

P2093

Amy P Schmidt

http://www.w3.org/2001/XMLSchema#string

Golnar Rasty

http://www.w3.org/2001/XMLSchema#string

Heather A Lankes

http://www.w3.org/2001/XMLSchema#string

Matthew Powell

http://www.w3.org/2001/XMLSchema#string

Michael L Pearl

http://www.w3.org/2001/XMLSchema#string

Nilsa C Ramirez

http://www.w3.org/2001/XMLSchema#string

Paul A DiSilvestro

http://www.w3.org/2001/XMLSchema#string

Paul J Goodfellow

http://www.w3.org/2001/XMLSchema#string

Rahel G Ghebre

http://www.w3.org/2001/XMLSchema#string

Robert S Mannel

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome

A Molecular Brake in the Kinase Hinge Region Regulates the Activity of Receptor Tyrosine Kinases

Cracking the Molecular Origin of Intrinsic Tyrosine Kinase Activity through Analysis of Pathogenic Gain-of-Function Mutations

Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation.

Integrated genomic characterization of endometrial carcinoma

Understanding the molecular basis of Apert syndrome

Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain

FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features

Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

The logrank test.

P304

366-373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2017.02.031

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

145

http://www.w3.org/2001/XMLSchema#string

P50

Pamela M. Pollock

Feng Gao

Sara A Byron

P577

2017-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28314589

http://www.w3.org/2001/XMLSchema#string

P932

5433848

http://www.w3.org/2001/XMLSchema#string